Gastroenterology Flashcards

1
Q

What is the most important cause of gastric and duodenal erosions?

a. H. pylori infection

b. Alcohol intake

c. NSAID use

d. Stress-related mucosal injury

A

NSAID use

♡ H. pylori (3.7) and NSAIDs (3.3)
– most common risk factors for PUD

■ UGIB
• Black tarry stool
• Coffee ground emesis
• Most common complication (likely NSAID-related)

■ Perforation
• Severe, generalized abdominal pain
• Second most common complication (likely NSAID-related)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following is the correct management of an ulcer visible as an adherent clot during endoscopy?

a. Endoscopic therapy + intensive PPI therapy + clear liquids for 2 days

b. Endoscopic therapy + once daily PPI therapy + clear liquids for 1 day

c. No endoscopic therapy + once daily PPI therapy + clear liquids for 1 day

d. No endoscopic therapy + once daily PPI therapy + regular diet

A

a. Endoscopic therapy + intensive PPI therapy + clear liquids for 2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A 72/F with osteoarthritis and chronic NSAID use came in at the emergency department due to hematochezia. Initial vital signs were BP 80/50, HR 121, RR 22. Hypotension was unresponsive to fluid resuscitation hence an inotrope was started. Her BP remains labile while on inotropes. What is the best course of management?

a. Upper endoscopy

b. Flexible sigmoidoscopy

c. Colonoscopy

d. Angiography

A

d. Angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

35/F presented at the ER due to melena. She was already treated for peptic ulcer disease 6 months ago with proton pump inhibitors. Review of systems also revealed intermittent diarrhea, sometimes steatorrhea. Review of the endoscopic report revealed multiple ulcers, involving the antrum, and the first and second part of the duodenum. H. pylori test was negative. Which of the following should be considered in this patient?

a. Dieulafoy lesion

b. Heyde’s syndrome

c. Zollinger-Ellison syndrome

d. MEN2 syndrome

A

■GASTRINOMA (ZOLLINGER-ELLISON SYNDROME)
– Gastrinoma is an NET that secretes gastrin
• resultant hypergastrinemia
• Results in marked gastric acid hypersecretion and growth of the gastric mucosa with increased numbers of parietal cells and proliferation of gastric ECL cells

– Clinical Manifestations:
🔅 Peptic ulcer disease (PUD) and Diarrhea often refractory and severe
🔅 Most common presenting symptoms
• Abdominal pain (70–100%)
• diarrhea (37–73%)
• Gastroesophageal reflux disease (GERD) (30–35%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which of the following common causes of acute pancreatitis can present with normal amylase and lipase levels?

a. Gallstones

b. Alcohol

c. Hypertriglyceridemia

d. Anti-HIV medications

A

c. Hypertriglyceridemia

Amylase values may be normal if (1) there is a delay (2–5 days) before blood samples are obtained, (2) the under-lying disorder is chronic pancreatitis rather than acute pancreatitis, or (3) hypertriglyceridemia is present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

45/F is consulting at the ER due to severe epigastric pain, described as steady and boring, radiating to the back, with associated loss of appetite. Vital signs are as follows: BP 100/60, HR 112, RR 21, Temp 37.8°C. Bowel sounds are diminished. She is not jaundiced. Murphy’s, psoas, obturator, Cullen and Turner signs are also negative. Which of the following should be part of the initial management plan for this patient?

a. Low-fat solid diet

b. Initial bolus of 1L of plain normal saline

c. Abdominal CT scan to look for necrosis

d. ERCP within 24 hours of diagnosis

A

b. Initial bolus of 1L of plain normal saline
¤ Bowel rest: NPO
¤ Place on O2
¤ Hydration: aggressive intravenous fluid resuscitation.
1. PLRS bolused at 15–20 mL/kg (1050–1400 mL) followed by
2. PLRS 2–3 mL/kg per hour (200–250 mL/h),
• Maintain urine output >0.5 mL/kg per hour.
• Decrease in HCT and BUN during the first 12–24 is strong evidence that sufficient fluids are being administered.
• Increase hematocrit or BUN during serial measurement should be treated with a repeat volume challenge with a 2-L crystalloid bolus followed by increasing the fluid rate by 1.5 mg/kg per hour.
• If the BUN or hematocrit fails to respond (i.e., remains elevated or does not decrease) to this bolus challenge and increase in fluid rate, consideration of transfer to an intensive care unit is strongly recommended for hemodynamic monitoring.

** Lactated Ringer decreases systemic inflammation and is better than crystalloid
** BUN, HCT every 8-12 hours
** Serial bedside evaluation every 6-8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

35/F experiences chest pain described as substernal warmth that moves to the neck, with associated dysphagia and occasional nonproductive cough. She has weight loss of 1 kg over the last 2 months after taking diet pills. Her mother died of breast cancer. Which of the following is a concerning feature of her dyspepsia?

a. Dysphagia

b Nonproductive cough

c. Weight loss

d. Family history of malignancy

A

Dysphagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which of the following patients can be diagnosed with functional dyspepsia in the absence of organic cause?

a. 2-week history of bothersome postprandial fullness

b. 4-week history of early satiety

c. 3-month history of vague epigastric pain

d. 6-month history of epigastric burning pain

A

d. 6-month history of epigastric burning pain

■ Functional Dyspepsia
– bothersome postprandial fullness, early satiety, or epigastric pain or burning
– onset at least 6 months before diagnosis in the absence of organic cause.
– Subdivided into
• Postprandial distress syndrome: meal-induced fullness and early satiety
• Epigastric pain syndrome: epigastric pain or burning which may or may not be meal-related. Most cases follow a benign course, but some with H. pylori infection or on nonsteroidal anti-inflammatory drugs (NSAIDs) develop ulcers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which of the following is a rare gastropathy characterized by large, tortuous mucosal folds most prominent in the body and fundus, sparing the antrum, eventually developing protein-losing gastropathy accompanied by hypoalbuminemia and edema?

a. Menetrier’s disease

b. Russel body gastritis

c. Zollinger-Ellison syndrome

d. Afferent loop syndrome

A

a. Menetrier’s disease
– mucosal folds in MD are often most prominent in the body and fundus, sparing the antrum.
– Clinical Presentation
• insidious and progressive.
• Epigastric pain, nausea, vomiting, anorexia
• peripheral edema, and weight loss
• Occult GI bleeding may occur, but overt bleeding is unusual and, when present, is due to superficial mucosal erosions
• protein-losing gastropathy due to hypersecretion of gastric mucus accompanied by hypoalbuminemia and edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following patients has a disease traditionally associated with type A gastritis?

a. Patient who tested positive for urea breath test

b. Patient with friable, ulcerated mass with irregular, thickened margins on the stomach

c. Patient with impaired production of intrinsic factor

d. Patient with colicky abdominal pain, transmural inflammation of the ileum, with fistula formation

A

c. Patient with impaired production of intrinsic factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the following hepatitis profiles is consistent with acute hepatitis B infection?

a. HBsAg negative, anti-HBs negative, anti-HBc IgG positive, anti-HBe positive

b. HBsAg negative, anti-HBs positive, anti-HBc negative, anti-HBe negative

c. HBsAg positive, anti-HBs negative, anti-HBc IgM positive, HBeAg positive

d. HBsAg positive, anti-HBs negative, anti-HBc IgG positive, HBeAg positive

A

d. HBsAg positive, anti-HBs negative, anti-HBc IgG positive, HBeAg positive

  • HBsAg negative, anti-HBs negative, anti-HBc IgG positive, anti-HBe positive (low-level chronic carrier)
  • HBsAg negative, anti-HBs positive, anti-HBc negative, anti-HBe negative (immunization)
  • HBsAg positive, anti-HBs negative, anti-HBc IgM positive, HBeAg positive (Acute; high infectivity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which of the following is TRUE of hepatitis B infection in adults?

a. Can be transmitted thru orofecal route

b. Neonatal transmission is related to breastfeeding from infected mothers

c. Does not usually progress to a chronic infection

d. Not documented to cause hepatocellular cancer

A

c. Does not usually progress to a chronic infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A 26/F was referred to you by a company physician. She just had her routine annual physical examination and check-up and laboratory results showed anti-HBc IgM was positive, but HBsAg, anti-HBs, HBeAg, and anti-Hbe were negative. Which of the following is a correct interpretation of this hepatitis profile?

a. Low level hepatitis B carrier

b. Immunized (after vaccination)

c. HBeAg-negative “precure mutant”

d. Anti-HBc “window”

A

Anti-HBc “window

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the following laboratory findings is most compatible with alcoholic hepatitis?

a. ALT > 400 IU/L

b. AST/ALT ratio <1

c. Elevated GGTP

d. Hyperbilirubinemia with marked increase in alkaline phosphatase

A

ALT/AST
• Modest increase = fatty liver
• may be 2-7x elevated (but rarely >400IU)

Lipid profile
• Hypertriglyceridemia, hypercholesterolemia

TB, DB
• Hyperbilirubinemia

Albumin, PTPA
• deranged synthetic function indicates a more serious disease

Liver biopsy
• can be helpful to confirm a diagnosis
withheld until abstinence has been maintained for at least 6 months to determine residual, nonreversible disease

γ-glutamyl transpeptidase (GGTP)= elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which risk assessment score predicts failure of glucocorticoid treatment in alcoholic liver disease?

a. Discriminant function ≥ 32

b. Model for end-stage liver disease (MELD) score ≥ 21

c. MELD-Na score ≥ 21

d. Lille score > 0.45

A

d. Lille score > 0.45

Lille Score
– Pretreatment variables + change in total bilirubin at day 7 of glucocorticoids
• If > 0.45: improved survival at 6 months; hence continue steroids
• If<0.45: poor survival at 6 months; steroids not beneficial
• May stop steroids at this time

• Indications for steroid therapy (either one of the following)
• Maddrey’s Discriminant Function>32 + Parameters: total bilirubin and PT/INR
• MELD>21
• Infection can be concurrently treated with antibiotics and steroids.
• Women with encephalopathy
• Exclusion criteria: active GI bleeding, renal failure, or pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most common agent implicated as causing drug-induced liver injury?

a. Amoxicillin-clavulanate

b. Acetaminophen (Paracetamol)

c. Ciprofloxacin

d. Steroids

A

a. Amoxicillin-clavulanate

17
Q

Which of the following drugs likely caused drug-induced hepatitis with the following laboratory findings: ALT 376 IU/L (upper limit of normal 45 IU/L), Alk phos 182 IU/L (upper limit of normal 147 IU/L)?

a. Amoxicillin-clavulanate

b. Isoniazid

c. Simvastatin

d. Oral contraceptives

A

Isoniazid

18
Q

Which of the following clinical manifestations is a sign of portal hypertension?

a. Jaundice

b. Ascites

c. Spider angioma

d. Hepatic encephalopathy

A

Ascites

19
Q

A 55/M with known chronic hepatitis B infection presents at the ER due to altered sensorium. He is awake but disoriented. He can follow commands and is positive for asterixis. Physical examination shows icteric sclerae, abdominal enlargement, caput medusae, spider nevi and bipedal edema. Which of the following is the correct management step in this case?

a. Restrict dietary proteins

b. Start lactulose to target at least one soft stool per day

c. Start octreotide drip and maintain for 2 to 5 days until sensorium normalizes

d. Start rifaximin 550 mg BID

A

d. Start rifaximin 550 mg BID

¤ Lactulose:
• colonic acidification
• elimination of nitrogenous products
• promote 2–3 soft stools per day.

¤ Rifaximin 500mg BID

** Dietary protein restriction: Ascites
** Ocreotide: UGIB in the presence of esophageal varices

20
Q

Which of the following clinical manifestations is more consistent with ulcerative colitis than in Crohn’s disease?

a. Gross blood and mucus in stool

b. May present with an abdominal mass

c. Frequently associated with significant perineal disease

d. Associated with fistula formation

A

a. Gross blood and mucus in stool

21
Q

What is the most common site of inflammation in Crohn’s disease?

a. part of duodenum

b. Terminal ileum

c. Jejunum

d. Colon and rectum

A

b. Terminal ileum